Bull
$715.22
Scenario price
$380.610
-1.180 (-0.31%)At close
Kinsale Capital Group, Inc. is a specialty insurance company that focuses on the excess and surplus lines (E&S) market in the United States. It writes E&S insurance on a non-admitted basis through its insurance subsidiary, Kinsale Insurance Company, which is authorized to write business in 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the United States Virgin Islands. It also markets certain products through its subsidiary, Aspera Insurance Services, Inc., an insurance broker. Its core client focus is small- to medium-sized accounts. Its commercial lines offerings include commercial property, excess casualty, general casualty, small business casualty, construction, allied health, entertainment, products liability, small business property, products liability, energy, environmental, management liability, inland marine, aviation, and all other commercial lines. Its personal lines offerings include high value homeowners and personal insurance.
Kinsale Capital Group Inc is currently trading at $380.61, which is near the average analyst price target of $390. The company has shown strong revenue growth, reporting $548.5 million in Q2, a 16.8% year-over-year increase. However, the RSI is at 48.63, indicating a neutral momentum, and insider selling has increased by 202.24%, which raises concerns about insider confidence. Therefore, while the company has solid fundamentals, the current market sentiment and insider activity suggest holding rather than buying.
Morgan Stanley
$390
2026-08-19
Morgan Stanley
2026-08-19
Price Target
$390
Morgan Stanley
$345
2026-07-29
Morgan Stanley
2026-07-29
Price Target
$345
JPMorgan
$390
2026-07-20
JPMorgan
2026-07-20
Price Target
$390
TD Cowen
$355
2026-06-16
TD Cowen
2026-06-16
Price Target
$355
RBC Capital
$375
2026-04-27
RBC Capital
2026-04-27
Price Target
$375
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Kinsale Capital Group Stock Rises 2.7% After Credit Upgrade

Kinsale Insurance Company Credit Rating Upgraded

Kinsale Capital Group Q2 Earnings Analysis

Kinsale Capital Group Declares Cash Dividend

Analysis of Three Stocks Viewed Bearishly by Wall Street
Kinsale Capital Group, Inc. is a specialty insurance company that focuses on the excess and surplus lines (E&S) market in the United States. It writes E&S insurance on a non-admitted basis through its insurance subsidiary, Kinsale Insurance Company, which is authorized to write business in 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the United States Virgin Islands. It also markets certain products through its subsidiary, Aspera Insurance Services, Inc., an insurance broker. Its core client focus is small- to medium-sized accounts. Its commercial lines offerings include commercial property, excess casualty, general casualty, small business casualty, construction, allied health, entertainment, products liability, small business property, products liability, energy, environmental, management liability, inland marine, aviation, and all other commercial lines. Its personal lines offerings include high value homeowners and personal insurance. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).
Kinsale Capital Group Inc is currently trading at $380.61, which is near the average analyst price target of $390. The company has shown strong revenue growth, reporting $548.5 million in Q2, a 16.8% year-over-year increase. However, the RSI is at 48.63, indicating a neutral momentum, and insider selling has increased by 202.24%, which raises concerns about insider confidence. Therefore, while the company has solid fundamentals, the current market sentiment and insider activity suggest holding rather than buying.
5 analysts cover KNSL: 3 rate it Buy, 2 Hold and 0 Sell. The average price target is 465.89.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.